Things are bad. But at least ‘you can eat’ one of these assets.
What happened Shares of Novavax (NASDAQ: NVAX) were bouncing back on Tuesday, rising 7.1% as of 12:50 p.m. ET after jumping as much as 14.7% earlier in the day. The gain came after an analyst's downgrade caused the stock to plunge last week.
BlackBerry Limited (NYSE: BB; TSX: BB) today reported financial results for the three months ended August 31, 2022 (all figures in U.S. dollars and U.S. GAAP, except where otherwise indicated).
The stock could surge as optimism surrounds its deliveries report
Medicare beneficiaries will see their Part B premiums go down for the first time in more than a decade, President Biden said during a press conference on Tuesday. Monthly Part B premiums, which are currently set at $170.10 in 2022, will decline to $164.90 in 2023 – a $5.20 a month savings, or about $64 a year, according to the Centers for Medicare and Medicaid Services. The annual deductible for Part B will be $226, down $7 from $233 in 2022.
The mortgage REIT completed a reverse split on Friday, so it's the first trading day post-split. A stock decline in this situation isn't odd at all.
Anyone following stock market trends in 2022 will be well aware of the widespread drawbacks; apart from some outliers such as energy, most corners of the market have been beaten to a pulp. The main culprits are easily identified by now; a combination of a slowing economy, rampant inflation, rates hikes to halt it, and Russia’s invasion of Ukraine and the global implications are all responsible factors. Stock market giants have not been immune either and many have seen huge chunks of their valuat
The CBOE Volatility Index has skyrocketed 89% so far this year. Morningstar put together a list of stocks with one- and three-year betas of 0.8 or lower. Then it screened for stocks that are undervalued, according to Morningstar analysts' fair value estimates.
The Federal Reserve will hike its key interest rate to a much higher peak than predicted two weeks ago and the risks are skewed towards an even higher terminal rate, according to economists polled by Reuters. That change in expectations came after the Fed raised rates by 75 basis points last week for the third straight meeting and foresaw going higher than it had previously thought to tame inflation, which is running over four times above target. Since then, already battered global stocks went much deeper into bear market territory - a decline of 20% or more - on fears of recession and most currencies weakened further against the multi-decade high dollar.
Barring selected periods of relief, the inherent trend of the stock market has been resolutely negative in 2022. For investors searching for ways to boost the portfolio’s performance, there have generally been slim pickings. But if you look on the bright side of a market situation where stocks are continuously pushed further down, what you get are some low and enticing entry points. Roth Capital’s tech and communications expert Scott Searle certainly thinks that with a bit of digging, investors
Riot Blockchain, Inc. (RIOT) closed the most recent trading day at $6.83, moving +1.94% from the previous trading session.
The 86-year-old investing legend has spoken. Pay attention.
Three men, including a father-and-son duo, were criminally charged on Monday with orchestrating a market manipulation scheme that briefly caused the owner of a tiny New Jersey deli to have a more than $100 million market valuation. Peter Coker Sr, 80, Peter Coker Jr, 53, and James Patten, 63, were charged by the U.S. Department of Justice in a 12-count indictment with securities fraud and conspiracy, while Patten was also charged with wire fraud, money laundering and securities manipulation. The U.S. Securities and Exchange Commission filed related civil charges.
The effects of rising interest rates continue to hit markets and none more so than in the mortgage sector. The amount of selling lately, for example, in Annaly Capital Management Inc. (NYSE: NLY) is remarkable for its extraordinary downward pressure on price levels. Here’s the daily price chart, to show you how extreme this is: [Chart 1] The upper and lower bands represent two standard deviations from the mean price — the mean is the dotted line in between them. Technical analyst John Bollinger
Visa (V) continues to invest in technology to further boost its already leading position in the payments market and minimize the impact of fraud, and protect consumer and merchant information.
One side effect of rising interest rates is the recent slide in high-yielding dividend stocks. The market is pummeling some widely held names, causing their yields to climb. Here are the yields on a handful of widely held S&P 500 stocks as of the Sept.
Not so long ago, in a galaxy not so far away, corporations thought they hit the jackpot. Not so long ago was 2021, and the galaxy in question was the United States of America. Institutions discovered a niche market that produced reliable, incredibly high yields. The market was real estate — single-family homes to be exact. They got a small taste early in 2020, taking advantage of some of the consequences families faced in the early stages of the pandemic. Institutions entered the rental market,
In this article, we will be taking a look at the 10 Best Cheap Technology Stocks to Invest In. To skip our analysis of the recent technology trends, and market activity, you can go directly to see the 5 Best Cheap Technology Stocks to Invest In. Technology has been at the forefront of advancement and […]
Shares of Tesla (NASDAQ: TSLA) were trading up over 4% earlier this morning before giving back those gains by early afternoon. What probably got the market off on a positive note was a small pullback in interest rates at the start of trading on Tuesday. Long-term U.S. Treasury rates have more than doubled year to date, which has pressured the valuations of expensive growth stocks like Tesla.
The coronavirus pandemic might, just might, be easing, but top COVID-19 vaccine maker Moderna (NASDAQ: MRNA) was ascendant on Tuesday. Shortly before market close on Monday, the Food and Drug Administration (FDA) announced it had authorized a set of Moderna's latest Spikevax COVID booster vaccine for use. Strictly speaking, that company isn't covered under Moderna's emergency use authorization (EUA) for the booster.